Skip to content
Search

Latest Stories

India's vaccination drive slow down amid shots shortage, infections rise

India's vaccination drive slow down amid shots shortage, infections rise

THE pace of Covid-19 vaccinations in India has slowed considerably from its record high early this month, as daily caseload spirals amid a shortage of doses in the country.

After having given and sold tens of millions of Covid-19 doses abroad, India is suddenly facing shortage of shots. Now to meet the demands amid a surge in Covid-19 cases, India has changed the rules to fast-track vaccine imports, having earlier turned down Pfizer.


According to the government's Co-Win portal to coordinate immunisations, vaccinations peaked at 4.5 million doses on April 5 but since then have averaged about 3 million a day.

India's number of cases has increased to 14.3 million, the most after the United States, with 174,308.

This month, the most number of cases in the world have been reported in the country with patients flooding hospitals, crematoriums and cemeteries filling up fast with the dead.

The raging second surge, has had sent people rushing to vaccination centres, but many centres are now rationing supplies as output fails to meet demand.

India is vaccinating only people aged above 45 years, having started the campaign in the middle of January with health and then other front-line workers. It has so far administered 115.5 million doses, the most in the world after the United States and China, though it ranks much lower when accounting for population.

Many states have sought an expansion of the inoculation drive to include all adults as cases rise, but the government has said doses are "finite", although enough to cover the identified groups.

The government said on Friday (16) the country had a stock of about 30 million doses. Going by India's immunisation trend in the past week, that will be enough to last 10 days.

As supplies tighten, India this week gave emergency authorisation to Russia's Sputnik V vaccine and imports to cover as many as 125 million people will start this month.

The government has also urged Pfizer, Moderna and Johnson and Johnson to sell their vaccines to India and has made rules easier for them.

India has also allowed biomedical research body Haffkine Institute, based in the western state of Maharashtra, to produce the home-grown shot Covaxin as developer Bharat Biotech struggles to boost its output.

The AstraZeneca vaccine, locally made by the Serum Institute of India (SII), accounts for more than 91 per cent of total doses given in the country. Production ramp-up at SII, the world's biggest vaccine maker, has been delayed by a raw-material shortage.

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
London temple project for Shree Banke Bihari launched

London temple project for Shree Banke Bihari launched

Mahesh Liloriya

The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.

The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”

Keep ReadingShow less
Dickie and Watt

Dickie and Watt launched BrewDog at the age of 24

Getty Images

BrewDog co-founder Martin Dickie leaves after 17 years as James Watt steps back

Highlights:

  • Martin Dickie has announced his departure from BrewDog and the alcohol industry.
  • He co-founded the Ellon-based brewer with James Watt in 2007.
  • Dickie cited family time and personal reasons for his exit.
  • His departure follows recent bar closures as part of a company restructuring.
  • BrewDog confirmed no further leadership changes will follow.

BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.

Early beginnings

Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.

Keep ReadingShow less